PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletionMartin J. van den Bent, Pim J. French, Marc Sanson et al.|Neuro-Oncology|2019Cited by 29
Supplementary Figure from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, <i>IDH</i>-wildtype: <i>Post Hoc</i> Analysis of the EORTC Randomized Phase III CATNON TrialC. Mircea S. Tesileanu, Martin J. van den Bent, Marc Sanson et al.|Unknown|2023Cited by 0